Fuso Pharmaceutical <4538.T>-6mth group results

Nov 6 (Reuters) -

FUSO PHARMACEUTICAL INDUSTRIES LTD

CONSOLIDATED FINANCIAL HIGHLIGHTS

(in billions of yen unless specified)

6 months ended 6 months ended Full year to Full year ended

Sep 30, 2009 Sep 30, 2008 Mar 31, 2010 Mar 31, 2009

LATEST YEAR-AGO COMPANY YEAR-AGO

H1 RESULTS H1 RESULTS FORECAST RESULTS
Sales 23.55 23.14 46.84

(+1.8 pct) (+2.0%)
Operating 152 mln 350 mln 640 mln

(-56.6 pct) (+116.2%)
Recurring loss 145 mln prft 254 mln prft 420 mln

(+388.4%)
Net loss 578 mln loss 190 mln loss 50 mln
EPS loss Y6.39 loss Y2.10 loss Y0.55
Annual div Y6.00 Y6.00
-Q2 div Y3.00 Y3.00
-Q4 div Y3.00 Y3.00

NOTE - Fuso Pharmaceutical Industries Ltd specialises in prescription drugs.

For latest earnings estimates made by Toyo Keizai, please
double click on 4538.TK1.